Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review

Background Optimal anti-epileptic drug (AED) treatment maximises therapeutic response and minimises adverse effects (AEs). Key to therapeutic AED treatment is adherence. Non-a...

Full description

Bibliographic Details
Main Authors: Kenneth R. Kaufman, Melissa Coluccio, Kartik Sivaraaman, Miriam Campeas
Format: Article
Language:English
Published: Cambridge University Press 2017-09-01
Series:BJPsych Open
Online Access:https://www.cambridge.org/core/product/identifier/S2056472400002349/type/journal_article
_version_ 1811157106115477504
author Kenneth R. Kaufman
Melissa Coluccio
Kartik Sivaraaman
Miriam Campeas
author_facet Kenneth R. Kaufman
Melissa Coluccio
Kartik Sivaraaman
Miriam Campeas
author_sort Kenneth R. Kaufman
collection DOAJ
description Background Optimal anti-epileptic drug (AED) treatment maximises therapeutic response and minimises adverse effects (AEs). Key to therapeutic AED treatment is adherence. Non-adherence is often related to severity of AEs. Frequently, patients do not spontaneously report, and clinicians do not specifically query, critical AEs that lead to non-adherence, including sexual dysfunction. Sexual dysfunction prevalence in patients with epilepsy ranges from 40 to 70%, often related to AEDs, epilepsy or mood states. This case reports lamotrigine-induced sexual dysfunction leading to periodic non-adherence. Aims To report lamotrigine-induced sexual dysfunction leading to periodic lamotrigine non-adherence in the context of multiple comorbidities and concurrent antidepressant and antihypertensive pharmacotherapy. Method Case analysis with PubMed literature review. Results A 56-year-old male patient with major depression, panic disorder without agoraphobia and post-traumatic stress disorder was well-controlled with escitalopram 20 mg bid, mirtazapine 22.5 mg qhs and alprazolam 1 mg tid prn. Comorbid conditions included complex partial seizures, psychogenic non-epileptic seizures (PNES), hypertension, gastroesophageal reflux disease and hydrocephalus with patent ventriculoperitoneal shunt that were effectively treated with lamotrigine 100 mg tid, enalapril 20 mg qam and lansoprazole 30 mg qam. He acknowledged non-adherence with lamotrigine secondary to sexual dysfunction. With lamotrigine 300 mg total daily dose, he described no libido with impotence/anejaculation/anorgasmia. When off lamotrigine for 48 h, he described becoming libidinous with decreased erectile dysfunction but persistent anejaculation/anorgasmia. When off lamotrigine for 72 h to maximise sexual functioning, he developed auras. Family confirmed patient's consistent monthly non-adherence for 2–3 days during the past year. Conclusions Sexual dysfunction is a key AE leading to AED non-adherence. This case describes dose-dependent lamotrigine-induced sexual dysfunction with episodic non-adherence for 12 months. Patient/clinician education regarding AED-induced sexual dysfunction is warranted as are routine sexual histories to ensure adherence.
first_indexed 2024-04-10T05:00:29Z
format Article
id doaj.art-976fd8d8573e4e2aa27a716869a482c4
institution Directory Open Access Journal
issn 2056-4724
language English
last_indexed 2024-04-10T05:00:29Z
publishDate 2017-09-01
publisher Cambridge University Press
record_format Article
series BJPsych Open
spelling doaj.art-976fd8d8573e4e2aa27a716869a482c42023-03-09T12:28:42ZengCambridge University PressBJPsych Open2056-47242017-09-01324925310.1192/bjpo.bp.117.005538Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature reviewKenneth R. Kaufman0Melissa Coluccio1Kartik Sivaraaman2Miriam Campeas3Departments of Psychiatry, Neurology and Anesthesiology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USADepartment of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USADepartment of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USADepartment of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA Background Optimal anti-epileptic drug (AED) treatment maximises therapeutic response and minimises adverse effects (AEs). Key to therapeutic AED treatment is adherence. Non-adherence is often related to severity of AEs. Frequently, patients do not spontaneously report, and clinicians do not specifically query, critical AEs that lead to non-adherence, including sexual dysfunction. Sexual dysfunction prevalence in patients with epilepsy ranges from 40 to 70%, often related to AEDs, epilepsy or mood states. This case reports lamotrigine-induced sexual dysfunction leading to periodic non-adherence. Aims To report lamotrigine-induced sexual dysfunction leading to periodic lamotrigine non-adherence in the context of multiple comorbidities and concurrent antidepressant and antihypertensive pharmacotherapy. Method Case analysis with PubMed literature review. Results A 56-year-old male patient with major depression, panic disorder without agoraphobia and post-traumatic stress disorder was well-controlled with escitalopram 20 mg bid, mirtazapine 22.5 mg qhs and alprazolam 1 mg tid prn. Comorbid conditions included complex partial seizures, psychogenic non-epileptic seizures (PNES), hypertension, gastroesophageal reflux disease and hydrocephalus with patent ventriculoperitoneal shunt that were effectively treated with lamotrigine 100 mg tid, enalapril 20 mg qam and lansoprazole 30 mg qam. He acknowledged non-adherence with lamotrigine secondary to sexual dysfunction. With lamotrigine 300 mg total daily dose, he described no libido with impotence/anejaculation/anorgasmia. When off lamotrigine for 48 h, he described becoming libidinous with decreased erectile dysfunction but persistent anejaculation/anorgasmia. When off lamotrigine for 72 h to maximise sexual functioning, he developed auras. Family confirmed patient's consistent monthly non-adherence for 2–3 days during the past year. Conclusions Sexual dysfunction is a key AE leading to AED non-adherence. This case describes dose-dependent lamotrigine-induced sexual dysfunction with episodic non-adherence for 12 months. Patient/clinician education regarding AED-induced sexual dysfunction is warranted as are routine sexual histories to ensure adherence. https://www.cambridge.org/core/product/identifier/S2056472400002349/type/journal_article
spellingShingle Kenneth R. Kaufman
Melissa Coluccio
Kartik Sivaraaman
Miriam Campeas
Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
BJPsych Open
title Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
title_full Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
title_fullStr Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
title_full_unstemmed Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
title_short Lamotrigine-induced sexual dysfunction and non-adherence: case analysis with literature review
title_sort lamotrigine induced sexual dysfunction and non adherence case analysis with literature review
url https://www.cambridge.org/core/product/identifier/S2056472400002349/type/journal_article
work_keys_str_mv AT kennethrkaufman lamotrigineinducedsexualdysfunctionandnonadherencecaseanalysiswithliteraturereview
AT melissacoluccio lamotrigineinducedsexualdysfunctionandnonadherencecaseanalysiswithliteraturereview
AT kartiksivaraaman lamotrigineinducedsexualdysfunctionandnonadherencecaseanalysiswithliteraturereview
AT miriamcampeas lamotrigineinducedsexualdysfunctionandnonadherencecaseanalysiswithliteraturereview